Orchid Pharma Ltd Share Price
As on 13 June 2026 at 01:08 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
17.48%
Over 6 Months
-0.35%
Over 1 Year
17.83%
Over 3 Years
103.77%
Orchid Pharma Ltd Summary
Close ₹845.95
Open ₹845
High ₹875.95
Low ₹827.90
Volume 1,66,387
Net Turnover (in Cr) ₹14.18
52Wk High ₹899
52Wk Low ₹480
52Wk High / Low
480
899
Orchid Pharma Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹4,290.58
EPS (TTM) 10.21
Book Value (BV) 270.14
Div. Yield -
P/E (TTM) 95.67
Price/Book Value 3.16
Delivery % 39.15 %
Face Value 10
Key Ratios
PE Ratio 37.01
PB Ratio 3.14
EV to Sales 4.29
PEG Ratio 2.99
ROA 7.09
ROE 3.32
Debt-Equity 0.12
Net Profit Margin 11.55
Operating Profit Margin 16.90
Orchid Pharma Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 949.40 | 850.23 | 685.33 | 568.56 | 465.27 |
| Total Expenses | 853.84 | 758.29 | 669.29 | 625.46 | 560.52 |
| Profit Before Tax | 95.56 | 91.95 | 55.25 | -56.90 | -95.25 |
| Profit After Tax | 95.76 | 95.06 | 55.25 | -56.90 | -95.25 |
| Operating Profit After Depreciation | 110.10 | 108.30 | 48.26 | -24.89 | -43.91 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 648.93 | 634.51 | 573.09 | 583.70 | 670.45 |
| Total Non Current Assets | 880.50 | 763.12 | 724.20 | 712.91 | 687.39 |
| Total Current Assets | 807.42 | 790.75 | 501.01 | 397.65 | 549.86 |
| Total Assets | 1,687.91 | 1,553.87 | 1,225.21 | 1,110.56 | 1,237.25 |
| Total Shareholder's Fund | 1,267.29 | 1,169.47 | 688.65 | 647.38 | 652.91 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 19.22 | 125.99 | 18.34 | 92.47 | 23.59 |
| Net Cash Used In Investing Activities | -26.93 | -312.03 | -31.21 | 112.94 | 67.21 |
| Net Cash Used In Financing Activities | 25.22 | 167.04 | 31.17 | -216.80 | -164.99 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 953.86 | 849.76 | 685.33 | 565.98 | 457.16 |
| Total Expenses | 847.37 | 758.23 | 669.29 | 618.75 | 553.03 |
| Profit Before Tax | 106.48 | 91.52 | 55.25 | -52.77 | -95.87 |
| Profit After Tax | 106.48 | 94.75 | 55.25 | -52.77 | -95.87 |
| Operating Profit After Depreciation | 121.02 | 107.85 | 48.26 | -20.76 | -44.54 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 629.47 | 630.71 | 573.06 | 583.65 | 670.39 |
| Total Non Current Assets | 910.19 | 769.91 | 729.46 | 711.12 | 682.22 |
| Total Current Assets | 786.39 | 782.29 | 493.79 | 383.07 | 542.25 |
| Total Assets | 1,696.58 | 1,552.20 | 1,223.26 | 1,094.19 | 1,224.47 |
| Total Shareholder's Fund | 1,324.05 | 1,218.32 | 731.96 | 677.95 | 681.34 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 27.48 | 130.73 | 13.39 | 89.57 | 24.36 |
| Net Cash Used In Investing Activities | -37.35 | -315.81 | -26.70 | 112.93 | 67.21 |
| Net Cash Used In Financing Activities | 25.44 | 167.07 | 31.17 | -216.80 | -164.99 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 237.61 | 207.27 | 193.52 | 172.93 | 237.48 |
| Total Expenses | 210.74 | 205.70 | 195 | 158.76 | 209.50 |
| Profit Before Tax | 22.79 | -12.14 | -3.34 | 13.71 | 19.09 |
| Profit After Tax | 22.79 | -12.15 | -3.33 | 13.71 | 19.13 |
| Operating Profit after Depreciation | 34.21 | 7.18 | 9.29 | 25.62 | 31.88 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 237.61 | 207.27 | 193.52 | 172.93 | 237.48 |
| Total Expenses | 208.61 | 204.43 | 194.20 | 158.75 | 203.15 |
| Profit Before Tax | 30.61 | -5.82 | 2.23 | 18.20 | 27.85 |
| Profit After Tax | 30.60 | -5.82 | 2.23 | 18.20 | 27.85 |
| Operating Profit after Depreciation | 42.30 | 13.43 | 14.75 | 30.11 | 40.59 |
Orchid Pharma Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 823.92
S2 801.88
S3 775.87
Pivot 849.93
R1 871.97
R2 897.98
R3 920.02
Moving Average
20 SMA 776.04
50 SMA 662.11
100 SMA 646.48
200 SMA 709.26
Orchid Pharma Ltd Corporate Actions
No available data
Orchid Pharma Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Orchid Pharma Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Kotak Special Opportunites Fund | 2.38% |
| Kotak Consumption Fund | 1.36% |
| UTI-Value Fund | 1.17% |
| Quant Small Cap Fund | 0.86% |
| Kotak Multi Asset Allocation Fund - Reg | 0.54% |
Orchid Pharma Ltd News
Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore
Orchid Pharma rose 1.10% to Rs 723.50 after the company reported a 6.68% increase in consolidated net profit to Rs 23.78 crore for the fourth quarter ended March 2026, compared with Rs 22.29 crore in the corresponding quarter last year.
26 May 2026, 09:59 am
Orchid Pharma to hold board meeting
On 25 May 2026
20 May 2026, 05:25 pm
Orchid Pharma to conduct board meeting
On 11 February 2026
07 Feb 2026, 10:24 am
Orchid Pharma to hold board meeting
On 11 November 2025
05 Nov 2025, 05:27 pm
Orchid Pharma schedules AGM
On 20 September 2025
19 Aug 2025, 05:40 pm
Orchid Pharma Ltd Stock Analysis
- Annual revenue for Orchid Pharma Ltd increased by 12.25% to ₹953.86 crore in FY 2025 from ₹849.76 crore in FY 2024.
- Annual Net Profit for Orchid Pharma Ltd increased by 12.38% to ₹106.48 crore in FY 2025 from ₹94.75 crore in FY 2024.
- Promoter Shareholding in Orchid Pharma Ltd remains unchanged by 0.00% in the most recent quarter, from 69.84% in December 2025 to 69.84% in March 2026.
- Orchid Pharma Ltd delivered a 1-year return of 17.83% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Orchid Pharma Ltd share price moved up by 2.63% from its previous close of INR ₹845.95. The latest Orchid Pharma Ltd share price is INR ₹868.20.
- Orchid Pharma Ltd share price today has been at a low of 847 and a high of 875. Over the past 52 weeks, the Orchid Pharma Ltd share price has seen a low of 480 and a high of 899.
FAQ’s
What is the share price of Orchid Pharma Ltd today?
Orchid Pharma Ltd share price as on 12 Jun 2026 is ₹ 868.2
What is the Market Cap of Orchid Pharma Ltd?
The market cap of Orchid Pharma Ltd stock is ₹4,290.58 Cr.
What is the PE Ratio of Orchid Pharma Ltd?
The Price to Earnings (P/E) Ratio of Orchid Pharma Ltd is 37.01
What is the PB Ratio of Orchid Pharma Ltd?
The Price to Book (P/B) Ratio of Orchid Pharma Ltd is 3.14
What is the 52 week high of Orchid Pharma Ltd Share Price?
The 52 week high of Orchid Pharma Ltd share price stands at ₹899
What is the 52 week low of Orchid Pharma Ltd Share Price?
The 52 week low of Orchid Pharma Ltd share price stands at ₹480
How can I buy shares of Orchid Pharma Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Orchid Pharma Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
